The content on this site is intended for healthcare professionals only
Dr Divyanshu Dua speaks to ecancer at the SIOG 2019 meeting in Geneva about the importance of SIOG advanced courses in Australia.
He explains that, due to an increasingly ageing population and with Australia and also Japan among the countries with the oldest populations, it is increasingly important to have a workforce that is specifically trained with older patients.
Dr Dua believes that as more people are trained by these courses there will be an increase in public voices and lobbying which will in turn positively impact funding.
This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
